890 related articles for article (PubMed ID: 3105322)
21. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
22. Expression of Tac antigen in B cell lymphomas.
Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
[TBL] [Abstract][Full Text] [Related]
23. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
[TBL] [Abstract][Full Text] [Related]
24. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
Knowles DM
Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
[TBL] [Abstract][Full Text] [Related]
26. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
27. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of immunohistological bone marrow examination: results in 212 patients with lymphoproliferative disorders.
Thaler J; Denz H; Gattringer C; Glassl H; Lechleitner M; Dietze O; Huber H
Blut; 1987 Apr; 54(4):213-22. PubMed ID: 3103722
[TBL] [Abstract][Full Text] [Related]
29. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
30. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
31. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
Liendo C; Danieu L; Al-Katib A; Koziner B
Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
[TBL] [Abstract][Full Text] [Related]
33. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
34. The identification and classification of non-hodgkin's lymphoma: A review.
Wright DH
Diagn Histopathol; 1982; 5(2):73-111. PubMed ID: 7047122
[No Abstract] [Full Text] [Related]
35. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
36. Immunologic aspects and pathology of the malignant lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
[TBL] [Abstract][Full Text] [Related]
37. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.
Picker LJ; Weiss LM; Medeiros LJ; Wood GS; Warnke RA
Am J Pathol; 1987 Jul; 128(1):181-201. PubMed ID: 3111266
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2 receptor is functionally linked with in vitro activation of B cells isolated from non-Hodgkin's lymphomas.
Garraud O; LeGrand E; Eghbali H; Hoerni-Simon G; Hoerni B; Guillemain B
Diagn Clin Immunol; 1988; 5(6):417-20. PubMed ID: 3265363
[TBL] [Abstract][Full Text] [Related]
40. Expression and signal transduction of T-cell antigen receptor (TCR)/CD3 complexes on fresh or in vitro expanded T lymphocytes from patients with Hodgkin's and non-Hodgkin's lymphomas.
Rubin B; Martin EP; Arnaud J; Delsol G; Plesner T; Ratsimbazafy A; Llobera R; Holm B; Mariame B
Scand J Immunol; 1997 Jun; 45(6):715-25. PubMed ID: 9201313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
